Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02361619Phase 1Completed
Phase 1, open-label, single-arm trial of dabigatran, sponsored by Turku University Hospital. Primary endpoint: Area Under the Curve of dabigatran in plasma at 24 hours. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02361619.